Adam W Feinberg, PhD

Dr. Feinberg is the principal investigator of the Regenerative Biomaterials and Therapeutics Group, founded at Carnegie Mellon University in 2010.  He earned his BS in Materials Science and Engineering from Cornell University in 1999 with co-op experience at Abiomed, Inc., working on total artificial hearts. This was followed by MS and PhD degrees in Biomedical Engineering from the University of Florida, where his doctoral work focused on engineering cell-material interactions to prevent and enhance adhesion.  Dr. Feinberg then moved to Harvard University as a Postdoctoral Fellow working on developing new biomaterials and cardiac tissue engineering strategies for 3-dimensional myocardial regeneration, with a focus on stem cell-based approaches (and two publications in Science). He subsequently joined CMU in the fall of 2010 as an Assistant Professor with joint appointments in Biomedical Engineering and Materials Science and Engineering.  Throughout his career Dr. Feinberg has co-authored over 15 peer-reviewed publications and holds 10 US patents and patent applications.  As an Assistant Professor, Dr. Feinberg has received the NIH Director’s 2012 New Innovator Award and the 2013 Ladd Research Award from the Carnegie Institute of Technology at CMU.

Researcher ID list of publications
Google Scholar Citations


Patents (Issued & Pending)

  1. “Surface Topography for Non-toxic Bioadhesion Control,” US Patent No. 7,143,709.
  2. “Surface Topographies for Non-toxic Bioadhesion Control,” US Patent No. 7,650,848.
  3. “Engineered Cell Growth on Polymeric Films and Biotechnological Applications Thereof,” US Patent No. 8,492,150.
  4. “Boundary Conditions for the Alignment of Cells and Tissues,” US 2010/0330644 A1.
  5. “Method for Generating Functionalized Soft Substrates and Micropatterning Cells Thereon,” US 2011/0189719 A1.
  6. “High Throughput Assays for Determining Contractile Function and Devices for Use Therein,” WO/2010/127280.
  7. “Methods of Generating Engineered Innervated Tissue and Uses Thereof,” WO/2011/102991.
  8. “Tissue Engineered Myocardium And Methods Of Production And Uses Thereof,” WO/2010/042856.